Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Improving Translational Research Outcomes for Opioid Use Disorder Treatments
Jermaine D. Jones, Neil B. Varshneya, Thomas J. Hudzik, et al.
Current Addiction Reports (2021) Vol. 8, Iss. 1, pp. 109-121
Open Access | Times Cited: 11

Showing 11 citing articles:

Opioid use and abuse in adolescents and young adults; dealing with science, laws and ethics: Charming the COBRAS
Donald E. Greydanus, Ahsan Nazeer, Dilip R. Patel
Disease-a-Month (2025), pp. 101853-101853
Closed Access | Times Cited: 1
Targeting Unmet Clinical Needs in the Treatment of Alcohol Use Disorder
Falk W. Lohoff
Frontiers in Psychiatry (2022) Vol. 13
Open Access | Times Cited: 19
Sublingual dexmedetomidine (BXCL501) reduces opioid withdrawal symptoms: findings from a multi-site, phase 1b/2, randomized, double-blind, placebo-controlled trial
Jermaine D. Jones, Lavanya Rajachandran, Frank D. Yocca, et al.
The American Journal of Drug and Alcohol Abuse (2023) Vol. 49, Iss. 1, pp. 109-122
Open Access | Times Cited: 8
The potential role of opioid vaccines and monoclonal antibodies in the opioid overdose crisis
Suky Martinez, Hannah Harris, Thomas Chao, et al.
Expert Opinion on Investigational Drugs (2023) Vol. 32, Iss. 3, pp. 181-185
Open Access | Times Cited: 6
Interactions between lorcaserin and opioids: Ventilation and food-versus-drug choice
David R. Maguire
Pharmacology Biochemistry and Behavior (2023) Vol. 234, pp. 173673-173673
Open Access | Times Cited: 3
Promoting harm reduction as a treatment outcome in substance use disorders.
Andrew S. Huhn, Cassandra D. Gipson
Experimental and Clinical Psychopharmacology (2021) Vol. 29, Iss. 3, pp. 217-218
Closed Access | Times Cited: 7
The effects of acute oral naltrexone pretreatment on the abuse potential of intranasal methamphetamine, and the relationship between reward/punishment sensitivity and methamphetamine’s effects
Jermaine D. Jones, Mudassir Mumtaz, Nehal P. Vadhan, et al.
Behavioural Pharmacology (2022) Vol. 33, Iss. 4, pp. 255-265
Open Access | Times Cited: 4
Cold nociception as a measure of hyperalgesia during spontaneous heroin withdrawal in mice
Lyndsay Hastings, Emma V. Frye, Erika R. Carlson, et al.
Pharmacology Biochemistry and Behavior (2023) Vol. 235, pp. 173694-173694
Closed Access | Times Cited: 2
The subjective experience of heroin effects among individuals with chronic opioid use: Revisiting reinforcement in an exploratory study
Suky Martinez, Laura Brandt, Sandra D. Comer, et al.
Addiction Neuroscience (2022) Vol. 4, pp. 100034-100034
Open Access | Times Cited: 3
Interactions between Lorcaserin and Opioids: Ventilation and Food-Versus-Drug Choice
David R. Maguire
(2023)
Closed Access | Times Cited: 1
Un-Meetings as tools for translational idea generation: A semantic content analysis of an Opioid Crisis Un-Meeting
Reza Yousefi‐Nooraie, Robert J. White, Scott J. Steele, et al.
Journal of Clinical and Translational Science (2022) Vol. 6, Iss. 1
Open Access | Times Cited: 1
Page 1

Scroll to top